These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29436513)

  • 1. Overcoming clofazimine intrinsic toxicity: statistical modelling and characterization of solid lipid nanoparticles.
    Chaves LL; Lima S; Vieira ACC; Ferreira D; Sarmento B; Reis S
    J R Soc Interface; 2018 Feb; 15(139):. PubMed ID: 29436513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment of formulation variables and intestinal permeability.
    Chaves LL; Costa Lima SA; Vieira ACC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
    Eur J Pharm Sci; 2018 Jan; 112():28-37. PubMed ID: 29122712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosystems as modulators of intestinal dapsone and clofazimine delivery.
    Chaves LL; Costa Lima SA; Vieira ACC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
    Biomed Pharmacother; 2018 Jul; 103():1392-1396. PubMed ID: 29864923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
    Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
    Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
    Chokshi NV; Khatri HN; Patel MM
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widening the Therapeutic Perspectives of Clofazimine by Its Loading in Sulfobutylether β-Cyclodextrin Nanocarriers: Nanomolar IC
    Wankar J; Bonvicini F; Benkovics G; Marassi V; Malanga M; Fenyvesi E; Gentilomi GA; Reschiglian P; Roda B; Manet I
    Mol Pharm; 2018 Sep; 15(9):3823-3836. PubMed ID: 30024758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections.
    Valetti S; Xia X; Costa-Gouveia J; Brodin P; Bernet-Camard MF; Andersson M; Feiler A
    Nanomedicine (Lond); 2017 Apr; 12(8):831-844. PubMed ID: 28338408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
    Pradhan M; Singh D; Singh MR
    Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid lipid nanoparticles for hydrophilic biotech drugs: optimization and cell viability studies (Caco-2 & HEPG-2 cell lines).
    Severino P; Andreani T; Jäger A; Chaud MV; Santana MH; Silva AM; Souto EB
    Eur J Med Chem; 2014 Jun; 81():28-34. PubMed ID: 24819957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway.
    Wang J; Zhu R; Sun X; Zhu Y; Liu H; Wang SL
    Int J Nanomedicine; 2014; 9():3987-98. PubMed ID: 25187702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles.
    Omwoyo WN; Ogutu B; Oloo F; Swai H; Kalombo L; Melariri P; Mahanga GM; Gathirwa JW
    Int J Nanomedicine; 2014; 9():3865-74. PubMed ID: 25143734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of Niclosamide loaded solid lipid nanoparticles: in vitro characterization and comparative in vivo evaluation.
    Rehman MU; Khan MA; Khan WS; Shafique M; Khan M
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1926-1934. PubMed ID: 29113501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Amphotericin B solid lipid nanoparticles: Design and development.
    Butani D; Yewale C; Misra A
    Colloids Surf B Biointerfaces; 2016 Mar; 139():17-24. PubMed ID: 26700229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.
    Sarangi B; Jana U; Sahoo J; Mohanta GP; Manna PK
    Biomed Microdevices; 2018 Jun; 20(3):53. PubMed ID: 29946758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.